Quarterly report [Sections 13 or 15(d)]

Note 18 - Warrants

v3.25.1
Note 18 - Warrants
3 Months Ended
Mar. 31, 2025
Notes to Financial Statements  
Warrants [Text Block]

NOTE 18  WARRANTS

 

The following table summarizes the Company's warrant activity for the three months ended March 31, 2025:

 

           

Weighted-

 
           

Average

 
           

Exercise

 
   

Warrants

   

Price

 

Warrants Outstanding as of January 1, 2025

    3,255,820     $ 2.41  

Issued

    7,812     $ 0.64  

Warrants Outstanding as of March 31, 2025

    3,263,632     $ 2.41  

 

In connection with the Unsecured Promissory Notes on January 8, 2025, the Company issued warrants to purchase up to 7,812 shares of Common Stock with an exercise price of $0.64. The warrants may be exercised at the election of the holder on a cashless basis in the event that the underlying common shares are unregistered. The warrants are exercisable until January 8, 2028 upon which the warrants shall be automatically exercised on a cashless basis. The warrants issued in connection with the Notes met the scope exception under ASC 815,Derivatives and Hedging” and are classified as equity instruments. Refer to "Note 13 - Notes Payable" for the Notes.
 
The fair value of the warrants issued during the three months ended March 31, 2025 was determined using the Black-Scholes simulation model based on Level 3 inputs on the fair value hierarchy. The following weighted average assumptions were used for the period presented:

 

   

March 31, 2025

 

Expected Term (in Years)

    3.0  

Volatility

    109.5 %

Risk-Free Interest Rate

    4.3 %

Dividend Yield

    0.0 %